Based in the United States, Broadwing Bio is a startup.
Broadwing Bio develops antibody therapies targeting genetically validated ophthalmology diseases such as Geographic Atrophy and Glaucoma to preserve vision and treat major causes of adult vision loss.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.